Delivery Order SPE2DB22D3016-SPE2DB25FBKF8
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Diazepam 10 mg/2 mL syringes with a ceiling value of $1,201.16. This is a firm fixed-price delivery order with a completion date of August 26, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The award was made on a competitive basis with...
- The Defense Logistics Agency awarded a delivery order valued at $1,004.16 to AmerisourceBergen Drug Corp for the supply of Diazepam 10 mg/2 ml syringes on a firm fixed price basis. This contract, issued on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was not set-aside and was competitively awarded through open competition. Performance of...
- The Defense Logistics Agency has awarded a delivery order valued at $1,116.00 to AmerisourceBergen Drug Corp for the supply of Diazepam 10 mg/2 mL syringes. This competitively awarded, firm fixed-price contract was executed on August 19, 2025, with an ultimate completion date of August 20, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation and represents a routine pharmaceutical procurement...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,400.94 on September 5, 2025, for the supply of Diazepam 5mg/ml vials (10 vials) to support federal medical procurement needs. This is a firm fixed-price delivery order with an ultimate completion date of October 2, 2025, awarded by the Medical Supply Chain division of the Defense Logistics Agency without a set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Diazepam 5mg/mL in 2mL vials, with a ceiling value of $4,316.75. This competitively awarded, firm fixed-price delivery order was issued and completed on August 12, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Diazepam 50 mg/10 ml vials with a ceiling value of $1,055.60 under a firm fixed-price contract. The award was made on September 17, 2025, with an ultimate completion date of September 18, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen will perform the work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Diazepam 5mg/mL vials (10-pack configuration). This competitively awarded, firm fixed-price delivery order carries a ceiling value of $4,682.38 and an ultimate completion date of October 20, 2025. The contract is not set-aside and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain for Diazepam 5mg/ml vials (10-count) with a ceiling value of $1,319.50. This firm fixed-price, competitively awarded contract is scheduled for completion by September 4, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-set-aside procurement, indicating the contract was competed among eligible vendors...
- The Defense Logistics Agency awarded a delivery order valued at $1,432.88 to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Diazepam 10 mg/2 ml Carpuject 2ml pharmaceutical products. This firm fixed price contract, which is not set-aside, represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to the...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Diazepam 5mg/mL in 2mL vials (10-count packages) with a ceiling value of $34,534.00. This competitively awarded, firm fixed-price delivery order will be completed by July 29, 2025, and performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's extensive role as...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBKF8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Diazepam 10 mg/2 mL syringes with a ceiling value of $1,643.99. This is a firm fixed-price delivery order with a completion date of September 22, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal vendor for military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive capability in delivering both brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. All of AmerisourceBergen's reviewed contract awards have been competitively awarded without set-asides, reflecting the company's ability to meet federal procurement requirements in open competition. The Defense Logistics Agency is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple awards for separate regions, positioning AmerisourceBergen to continue serving customers including the Defense Health Agency and U.S. Coast Guard through flexible contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 9/19/25 |